
Albert Bourla is the Chief Executive Officer and Chairman of Pfizer. Albert has held the CEO seat since January 2019.
Current company
Pfizer
Pfizer is an American multinational pharmaceutical and biotechnology corporation.
pharmaceutical industryHeadquartered in New York CityFounded 1849NYSE: PFE
Source: WikidataAlbert Bourla joined Pfizer in January 2004 and has been CEO since January 2019.
Career
Sources: LinkedIn profile
Education
Aristotle University of Thessaloniki (AUTH), Doctor of Philosophy (PhD), Biotechnology of ReproductionAristotle University of Thessaloniki (AUTH), Doctor of Veterinary Medicine (DVM)Source
660+ decision makers at Pfizer in Unify, vice president level and above. Choose a function to see who leads it.
Top decision makers at Pfizer
Vice president level and above, most senior firstAlbert Bourla leads a leadership team of 10 published executives. The most recent appointment is Chris Boshoff as Chief Scientific Officer and President, Research & Development, in seat since January 2025.
Most senior 5 of 10
| Name | Title | In seat since |
|---|---|---|
| Albert Bourla | Chairman and Chief Executive Officer | January 2019 |
| David M. Denton | Chief Financial Officer, Executive Vice President | May 2022 |
| Douglas M. Lankler | Chief Legal Officer, Executive Vice President | January 2025 |
| Andrew Baum | Chief Strategy and Innovation Officer and Executive Vice President | 2024 |
| Michael McDermott | Chief Global Supply and Quality Officer, Executive Vice President | January 2025 |
Sources: Pfizer 2025 Form 10-K
Albert Bourla is the Chief Executive Officer and Chairman of Pfizer. Albert has held the CEO seat since January 2019.
Albert Bourla has been CEO of Pfizer since January 2019, according to LinkedIn profile.
Albert Bourla has been CEO of Pfizer for 7 years, since January 2019.
David M. Denton (Chief Financial Officer, Executive Vice President), Douglas M. Lankler (Chief Legal Officer, Executive Vice President), Andrew Baum (Chief Strategy and Innovation Officer and Executive Vice President), Michael McDermott (Chief Global Supply and Quality Officer, Executive Vice President), and 5 more. Source: Pfizer 2025 Form 10-K.
The seat holder is identified in Unify's professional profile dataset, then confirmed against the company's published leadership page, its SEC filings, and Wikipedia before publication. Career and education rows carry the public document they were taken from. Leadership team membership follows the company's own leadership page; in-seat dates come from filings where available and otherwise from the profile record. Company figures are read from the Unify headcount page for the same company and are profile coverage measures, never company-reported workforce totals. The employee preview lists vice president and senior vice president level profiles by department. No personal contact details are published.